Irving-based Kimberly-Clark snaps up Tylenol maker Kenvue in a cash-and-stock blockbuster, uniting Kleenex, Huggies, and Band ...

The deal, expected to close in the second half of 2026, comes as Kenvue's Tylenol political fight is heating up.

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company ...

IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ ...

Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) ...

Kimberly-Clark said the combination would create a company with $32 billion in revenue and allow it to surpass Unilever Plc ...

In what is being called one of the largest corporate takeovers in years, Kimberly-Clark is buying Tylenol parent company, ...

Kimberly-Clark plans to acquire Kenvue in a $48.7 billion deal, aiming to boost long-term growth and synergies. Learn more ...

Kimberly-Clark announces the acquisition of Kenvue, the maker of Tylenol, in a landmark $48.7 billion deal to create a ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...